Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ICHR | ATHM |
|---|---|---|
| Price | $63.33 | $20.61 |
| Change today | ▲ 0.65% | ▲ 0.24% |
| Market cap | $2.37B | $2.37B |
| Return, 3 months | -25.5% | +10.4% |
| Return, year to date | +243.6% | -4.1% |
| Return, 1 year | +215.7% | -25.9% |
| P/E (TTM) | -54.1 | 17.1 |
| P/B | 2.7 | 0.7 |
| P/E percentile vs own 5y | 6th | 89th |
| Dividend yield | – | 12.21% |
| Revenue growth (YoY, latest qtr) | +22.7% | – |
| Net profit growth (YoY) | +110.6% | – |
| Gross margin | 10.4% | – |
| Operating margin | -2.4% | – |
| Net margin | -4.0% | – |
| Return on equity | -5.2% | – |
| Analyst target vs. price | +55.5% | -7.8% |
| Analyst buy share | 100% | 0% |
| RSI (14) | 59 | 35 |
| 30-day volatility | 57.0% | 21.9% |
| Max drawdown, 1 year | -54.5% | -44.2% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Buy | Sell |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
